GW Pharmaceuticals Provides Update on Cannabinoid Pipeline - MarketWatch

New drug derived from cbd in marajuana being developed as an add on agent for sz...looks promising since they're already testing it in people...anyway posting it in roll call since we talked about the oils and stuff on another roll call. It's amazing how fast all this moves.